A tailored course, built for your situation
Modern AI in Pharmaceutical R&D Operations for Audit Teams
Implementation-grade mastery for audit and compliance professionals navigating AI-driven R&D transformation
The situation this course is for
As AI systems accelerate drug discovery and clinical development, audit functions struggle to assess model provenance, data integrity, and change control in dynamic environments. Traditional audit approaches lack specificity for AI workflows, creating delays, compliance gaps, and misalignment with R&D teams.
Who this is for
Compliance officers, audit leads, quality assurance specialists, and technology risk professionals in pharmaceutical or life sciences organizations who need to assess, validate, and govern AI-integrated R&D operations.
Who this is not for
This course is not for data scientists building AI models or executives seeking high-level AI overviews. It is strictly for audit and compliance practitioners responsible for operational validation and governance.
What you walk away with
- Interpret AI model lifecycle stages within pharmaceutical R&D workflows
- Apply audit frameworks to AI training data, versioning, and revalidation cycles
- Evaluate compliance readiness of AI-augmented clinical trial design and execution
- Use structured templates to document AI system risk assessments and control testing
- Lead cross-functional alignment between audit, R&D, and data governance teams
The 12 modules (with all 144 chapters)
- Introduction to AI in pharma R&D
- Key drivers of AI adoption in life sciences
- Regulatory expectations for AI use
- Audit relevance of AI transformation
- Case study: AI in preclinical screening
- Case study: AI in clinical trial recruitment
- Emerging standards for AI governance
- Role of audit in AI oversight
- Common misconceptions about AI auditing
- Terminology alignment for audit teams
- Stakeholder map: R&D, compliance, IT, QA
- Course navigation and playbook overview
- What is machine learning?
- Supervised vs unsupervised learning
- Model training, validation, testing phases
- Understanding overfitting and underfitting
- Common algorithms in pharma R&D
- Neural networks and deep learning basics
- Natural language processing in clinical data
- Computer vision in lab imaging
- Model inputs and feature engineering
- Output interpretation and uncertainty
- Bias and fairness in model design
- Auditor’s checklist: model type validation
- Data provenance and lineage tracking
- Raw data collection in R&D settings
- Data cleaning and preprocessing logs
- Version control for datasets
- Metadata standards for AI inputs
- Data quality metrics and thresholds
- Annotating training data for transparency
- Audit trail requirements for data pipelines
- Third-party data vendors and compliance
- Patient data and privacy in AI models
- Data retention and deletion policies
- Template: Data governance audit worksheet
- Model development lifecycle stages
- Version control for AI models
- Code repositories and change logs
- Reproducibility and environment configuration
- Validation datasets and split strategies
- Performance metrics: accuracy, precision, recall
- Threshold selection and clinical impact
- Cross-validation and external validation
- Model documentation standards
- Change control for model updates
- Revalidation triggers and schedules
- Template: Model validation audit checklist
- AI for target discovery and validation
- Virtual screening of compound libraries
- Predictive toxicology models
- In silico pharmacology and ADMET
- Integration with lab automation systems
- Data sources for preclinical AI
- Model accuracy vs experimental validation
- Audit trail for simulation outputs
- Versioning of virtual screening runs
- Change control in preclinical workflows
- Regulatory expectations for in silico data
- Template: Preclinical AI audit pathway
- AI for protocol optimization
- Predictive site performance modeling
- Patient recruitment and eligibility matching
- Natural language processing of medical records
- Decentralized trial enrollment systems
- Risk-based monitoring with AI
- Adaptive trial design algorithms
- Data sources: EHR, claims, registries
- Bias in patient selection models
- Audit trail for AI-driven enrollment
- Compliance with ICH GCP and 21 CFR Part 11
- Template: Clinical AI audit framework
- Process analytical technology and AI
- Real-time release testing with AI
- Predictive maintenance in manufacturing
- Anomaly detection in production data
- AI for root cause analysis
- Integration with MES and LIMS
- Model validation for GMP processes
- Change control for production AI
- Audit trail integrity for automated decisions
- Regulatory submissions with AI-generated data
- Case study: AI in bioreactor optimization
- Template: Manufacturing AI audit checklist
- FDA AI/ML Software as a Medical Device guidance
- EMA perspective on AI in drug development
- ICH guidelines and AI implications
- Acceptability of in silico evidence
- Model validation for regulatory submission
- Documentation requirements for AI tools
- Audit trail standards for submission data
- Third-party AI tools in regulatory packages
- Transparency and explainability expectations
- Inspection readiness for AI components
- Post-approval change management
- Template: Regulatory audit preparation guide
- Black box vs interpretable models
- Local vs global explainability
- SHAP, LIME, and other explanation methods
- Clinical interpretability of AI outputs
- Documentation of model reasoning
- Audit trail for explanation generation
- Stakeholder communication of AI decisions
- Regulatory expectations for transparency
- Limitations of explainability techniques
- Bias detection through interpretability
- Case study: Explaining a failed prediction
- Template: Explainability audit worksheet
- AI risk taxonomies and categorization
- Risk-based audit planning for AI
- Integration with quality management systems
- AI-specific risk controls
- Third-party AI vendor risk assessment
- Cybersecurity considerations for AI systems
- Data integrity and ALCOA+ principles
- Change management for AI deployments
- Incident response for AI failures
- Audit program design for AI portfolio
- Reporting AI risks to leadership
- Template: AI risk register for audit use
- Stakeholder mapping for AI audits
- Establishing audit entry points in R&D
- Collaborative documentation practices
- Joint validation exercises
- Resolving technical-compliance disagreements
- Training R&D teams on audit expectations
- Communicating findings to non-technical leaders
- Audit influence in AI governance committees
- Managing audit scope creep in AI projects
- Balancing innovation and compliance
- Case study: Audit-led AI policy adoption
- Template: Stakeholder engagement playbook
- Generative AI in drug discovery
- Large language models for clinical documentation
- Autonomous lab systems and audit implications
- Federated learning and data privacy
- AI model marketplace risks
- Continuous learning and adaptive models
- Audit of self-updating AI systems
- Preparing for regulatory evolution
- Building internal AI audit capability
- Upskilling audit teams for AI fluency
- Strategic roadmap for AI audit maturity
- Final assessment and implementation planning
How this maps to your situation
- Auditing AI in early-stage drug discovery
- Validating AI use in clinical trial execution
- Assessing AI-generated data for regulatory submission
- Leading cross-functional AI governance initiatives
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 45, 60 hours of self-paced learning, designed for busy professionals.
How this compares to the alternatives
Unlike generic AI overviews or technical data science courses, this program is tailored specifically for audit and compliance professionals, offering implementation-grade depth with practical tools and pharmaceutical R&D context.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.